Skip to content
DraconiticResearch
Search Sources API
194,226 studies31 sourcesUpdated 43 min ago
Peer-reviewedLicence not statedMolecular cancer therapeutics

Activation of PP2A-B56α leads to aberrant EGFR signaling and proliferative phenotypes in PDAC

  • Claire M. Pfeffer1,2
  • Sydney J. Clifford1
  • Saadia A. Karim3
  • Ella Rose D. Chianis1
  • Brittany N. Heil1,2
  • Lauren E. Gartenhaus1,2
  • Emma F. Kay1
  • Garima Baral1
  • Elizabeth G. Hoffman1
  • Sagar M. Utturkar4
  • Harish Kothandaraman4
  • Whitney Smith-Kinnaman5
10 more authors
  • Kasi Hansen5
  • Emily G. Smith1
  • Elisabeth Porter6
  • Fu-Ping Zhang7
  • Nadia A. Lanman4,8
  • Jukka Westermarck9
  • Emma H. Doud5,10
  • Amber L. Mosley5,10
  • Jennifer P. Morton3,11
  • Brittany L. Allen-Petersen1,2,4
11 affiliations
  1. 1Department of Biological Sciences, Purdue University, West Lafayette, IN USA
  2. 2Purdue University Interdisciplinary Life Sciences Program (PULSe), West Lafayette, IN USA
  3. 3Cancer Research UK Scotland Institute, Glasgow, UK
  4. 4Purdue Institute for Cancer Research, West Lafayette, IN USA
  5. 5Center for Proteome Analysis, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA
  6. 6Department of Health and Human Sciences, Purdue University, West Lafayette, IN USA
  7. 7Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
  8. 8Department of Comparative Pathobiology, Purdue University, West Lafayette, IN, USA
  9. 9Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland
  10. 10Biochemistry and Molecular Biology, Indiana University School of Medicine, (IUSM), Indianapolis, IN, USA
  11. 11School of Cancer Sciences, University of Glasgow, Glasgow, UK
Read full textPDFDOICite

Related

  1. Aberrant CPS1 expression is linked to metabolic alterations and metastatic phenotypes in colorectal cancer liver metastasis
    Qin Xiang, Ming Yang, Xiaoyu Li +7
    Scientific ReportsPeer-reviewedCC BY 4.0Full textOncologyCrossref
  2. Collagen-dependent DDR1 ectodomain shedding regulates proliferative signaling in radiation-resistant glioblastoma
    S. Dunlap, C. A. Harvey, A. Elkholy +8
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  3. βKlotho filters ligand-independent FGFR1/4-PLCγ signaling to prevent aberrant constitutive Ca2+ entry
    Bao T. N. Dang, Phan Anh Nguyen, Subo Lee +2
    The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of PharmacologyPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  4. LIPT1 is associated with rheumatoid arthritis fibroblast phenotypes and Wnt-related signaling
    Shu Li, Lei Wan, Xiaojun Zhang +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  5. VGLL4 Suppresses Malignant Phenotypes of Clear Cell Renal Cell Carcinoma Cells Through Modulation of Hippo/YAP and Wnt/β-Catenin Signaling Pathways
    Yaru Zhang, Shuyao Wang, Zhipeng Zhao +3
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{pfeffer2026activation,
  title = {{Activation of PP2A-B56α leads to aberrant EGFR signaling and proliferative phenotypes in PDAC}},
  author = {Claire M. Pfeffer and Sydney J. Clifford and Saadia A. Karim and Ella Rose D. Chianis and Brittany N. Heil and Lauren E. Gartenhaus and Emma F. Kay and Garima Baral and Elizabeth G. Hoffman and Sagar M. Utturkar and Harish Kothandaraman and Whitney Smith-Kinnaman and Kasi Hansen and Emily G. Smith and Elisabeth Porter and Fu-Ping Zhang and Nadia A. Lanman and Jukka Westermarck and Emma H. Doud and Amber L. Mosley and Jennifer P. Morton and Brittany L. Allen-Petersen},
  journal = {Molecular cancer therapeutics},
  year = {2026},
  month = sep,
  doi = {10.1158/1535-7163.mct-25-0970},
  url = {https://doi.org/10.1158/1535-7163.mct-25-0970},
}
RIS
TY  - JOUR
TI  - Activation of PP2A-B56α leads to aberrant EGFR signaling and proliferative phenotypes in PDAC
AU  - Claire M. Pfeffer
AU  - Sydney J. Clifford
AU  - Saadia A. Karim
AU  - Ella Rose D. Chianis
AU  - Brittany N. Heil
AU  - Lauren E. Gartenhaus
AU  - Emma F. Kay
AU  - Garima Baral
AU  - Elizabeth G. Hoffman
AU  - Sagar M. Utturkar
AU  - Harish Kothandaraman
AU  - Whitney Smith-Kinnaman
AU  - Kasi Hansen
AU  - Emily G. Smith
AU  - Elisabeth Porter
AU  - Fu-Ping Zhang
AU  - Nadia A. Lanman
AU  - Jukka Westermarck
AU  - Emma H. Doud
AU  - Amber L. Mosley
AU  - Jennifer P. Morton
AU  - Brittany L. Allen-Petersen
PY  - 2026
DA  - 2026/09/04
JO  - Molecular cancer therapeutics
DO  - 10.1158/1535-7163.mct-25-0970
UR  - https://doi.org/10.1158/1535-7163.mct-25-0970
SN  - 1535-7163
SN  - 1538-8514
ER  -